Evidence map›Paper›PMID 41554973›Full record

ArticleNPJ digital medicine2026

LLM-driven collaborative framework for knowledge-enhanced cancer pain assessment and management.

Haixiao Liu, Yue Hu, Dongtao Li, Boyuan Shi, Yupeng Niu, Xinche Zhang, Guangda Zheng, Changlin Li, Lingyun Wang, Yanju Bao

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haixiao Liu *Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yue Hu *Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Dongtao Li *Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Boyuan ShiSchool of Biomedical Engineering, Tsinghua University, Beijing, China.
Yupeng NiuTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Xinche ZhangSchool of Biomedical Engineering, Tsinghua University, Beijing, China.
Guangda ZhengXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Changlin LiThe First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Lingyun WangThe First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Yanju BaoGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. drbaoyanju@163.com.

Funding

the Clinical Research and Achievement Transformation Capacity Enhancement Project for High-Level TCM Hospitals HLCMHPP2023078the Innovation Fund of the China Academy of Chinese Medical Sciences CI2021A01817the Innovation Key Fund of the China Academy of Chinese Medical Sciences YY3101202507001the National Natural Science Foundation of China 81302961
6 · The paper itself

Abstract

Due to its multi-factor mechanism, variable opioid response, and high-risk adverse reactions, cancer pain remains a major challenge in oncology. To overcome these obstacles, we have developed a collaboration framework based on large language models (LLMs): OncoPainBot. This framework can simulate the reasoning and decision-making of multiple clinical experts to conduct comprehensive cancer pain assessment and management. Our OncoPainBot integrates four specialized agents: Pain-Extraction, Pain-Mechanism Reasoning, Treatment-Planning, and Safety-Check, each corresponding to a unique clinical role. In this paper, we compare seven LLMs and three Retrieval-Augmented Generation(RAG) strategies to determine the optimal model configuration. The final framework was verified on 516 real-world electronic medical records of cancer pain collected. We tested our solution through multiple dimensions. Ultimately, Claude-4 combined with RAG achieved the best overall performance, demonstrating outstanding semantic consistency and evidence-based reasoning in multiple metrics. In clinical validation, OncoPainBot achieved a high degree of consistency between the generated reports and actual clinical documents, while maintaining a high decision-making accuracy (0.841) in the analgesic recommendation task. At the same time, our error analysis shows that most of the differences are caused by patient-specific factors and monitoring recommendations rather than incorrect drug selection, which demonstrates the reliability of our framework. OncoPainBot has demonstrated the feasibility of a cancer pain management system based on LLMs, providing a transparent, evidence-based, and clinical-based framework for personalized analgesic care.

Identifiers

PMID41554973
PMCPMC12917166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.